跳至主要内容
临床试验/NCT02915510
NCT02915510已完成不适用

Evaluating the Tolerance, Safety and Acceptability of PKU GMPro, a Whey Protein Derived Feed for the Dietary Management of Phenylketonuria in Children and Adults - a Pilot Trial

Nutricia UK Ltd5 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
5
主要终点
Blood Phenylalanine (and other amino acids)

研究概览

简要总结

This study will evaluate the safety, gastrointestinal (GI) tolerance, acceptability and compliance of a Glycomacropeptide-based protein substitute for patients with Phenylketonuria (PKU).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
3 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female
  • Over 3 years of age
  • Diagnosed with classical or variant type phenylketonuria
  • Have been compliant in taking at least one amino acid-based, Phe-free protein substitute, providing at least 20g protein equivalents, for at least 1 month prior to trial commencement
  • Have a prescribed daily Phe allowance
  • Written informed consent from patient, or from parent / carer if applicable

排除标准

  • Currently prescribed Sapropterin or similar tetrahydrobiopterin based medication
  • Pregnant or lactating
  • Requiring parenteral nutrition
  • Major hepatic or renal dysfunction
  • Participation in other studies within 1 month prior to entry of this study
  • Allergy to any of the study product ingredients, including milk protein or soya
  • Investigator concern around willingness/ability of patient or parent/carer to comply with protocol requirements

研究组 & 干预措施

GMP

Experimental

Single arm designed, 3 day baseline, 28day on GMP

干预措施: Glycomacropeptide-based protein substitute (Dietary Supplement)

结局指标

主要结局

Blood Phenylalanine (and other amino acids)

时间窗: 3 points throughout 28 days

Blood spot test

次要结局

  • Gastro-intestinal tolerance questionaire(12/31 days)
  • Product compliance questionaire(31 days)
  • Product acceptability questionnaire(2/31 days)
  • Patient reproted nutrient intake (3 day food diaries)(6/31 days)
  • Pateint-reported appetite (visual analogue scale)(6/31 days)
  • Antropometry (hieight and weight)(2/31 days)
  • Safety (Adverse events reporting)(31 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验